These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7558419)

  • 21. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells.
    Halline AG; Davidson NO; Skarosi SF; Sitrin MD; Tietze C; Alpers DH; Brasitus TA
    Endocrinology; 1994 Apr; 134(4):1710-7. PubMed ID: 8137734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiproliferative effect of 1,25-dihydroxyvitamin D3 and its analogs on human colon adenocarcinoma cells (CaCo-2): influence of extracellular calcium.
    Cross HS; Huber C; Peterlik M
    Biochem Biophys Res Commun; 1991 Aug; 179(1):57-62. PubMed ID: 1883380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells.
    Mathiasen IS; Colston KW; Binderup L
    J Steroid Biochem Mol Biol; 1993 Sep; 46(3):365-71. PubMed ID: 9831485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways.
    Chang PL; Lee TF; Garretson K; Prince CW
    Clin Exp Metastasis; 1997 Nov; 15(6):580-92. PubMed ID: 9344042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells.
    Love-Schimenti CD; Gibson DF; Ratnam AV; Bikle DD
    Cancer Res; 1996 Jun; 56(12):2789-94. PubMed ID: 8665515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
    Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
    Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D increases tight-junction conductance and paracellular Ca2+ transport in Caco-2 cell cultures.
    Chirayath MV; Gajdzik L; Hulla W; Graf J; Cross HS; Peterlik M
    Am J Physiol; 1998 Feb; 274(2):G389-96. PubMed ID: 9486194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a vitamin D3-resistant MCF-7 cell line.
    Narvaez CJ; Vanweelden K; Byrne I; Welsh J
    Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D receptors in breast cancer cells.
    Buras RR; Schumaker LM; Davoodi F; Brenner RV; Shabahang M; Nauta RJ; Evans SR
    Breast Cancer Res Treat; 1994; 31(2-3):191-202. PubMed ID: 7881099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance of HBL100 human breast epithelial cells to vitamin D action.
    Agadir A; Lazzaro G; Zheng Y; Zhang XK; Mehta R
    Carcinogenesis; 1999 Apr; 20(4):577-82. PubMed ID: 10223184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
    Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
    Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation.
    Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W
    J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells.
    Chen S; Bu D; Ma Y; Zhu J; Chen G; Sun L; Zuo S; Li T; Pan Y; Wang X; Liu Y; Wang P
    Neoplasia; 2017 Mar; 19(3):226-236. PubMed ID: 28189050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
    Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
    J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs.
    Hager G; Kornfehl J; Knerer B; Weigel G; Formanek M
    Acta Otolaryngol; 2004 Jan; 124(1):90-6. PubMed ID: 14977084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 1,25 dihydroxyvitamin D3 and calcium on growth and differentiation and on c-fos and p53 gene expression in normal human keratinocytes.
    Sebag M; Gulliver W; Kremer R
    J Invest Dermatol; 1994 Sep; 103(3):323-9. PubMed ID: 8077697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
    Yao J; Kathpalia P; Bushinsky DA; Favus MJ
    J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway.
    Hedlund TE; Moffatt KA; Miller GJ
    Endocrinology; 1996 May; 137(5):1554-61. PubMed ID: 8612485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.